Physician profile
Stanley E Friedell
NPI 1952499758
$5,319.34
in general payments reported to CMS, 2019-2025
30 companies · $574 in 2025
The $574 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $611 · 2021: $820 · 2022: $662 · 2023: $388 · 2024: $1,678 · 2025: $574.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,640 · Education: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,640.28 |
| Education | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,601.15 | 2019-2025 | |
| Intuitive Surgical, INC. | $1,000.00 | 2024 | |
| Pfizer INC. | $354.95 | 2019-2025 | |
| Roche Diagnostics Corporation | $285.59 | 2019-2020 | |
| Biogen, INC. | $209.23 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $202.31 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $191.41 | 2022-2025 | Nexplanon |
| Avion Pharmaceuticals | $189.10 | 2019-2023 | Balcoltra |
| Exeltis, USA INC. | $183.47 | 2019-2025 | Slynd |
| Therapeuticsmd, INC. | $112.20 | 2019-2021 | |
| Hologic Sales and Service, LLC | $108.15 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $103.36 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $103.33 | 2019-2024 | Gardasil 9, Gardasil, Vaqta |
| Agile Therapeutics, INC. | $92.40 | 2021 | |
| Mylan Pharmaceuticals INC. | $67.03 | 2019-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gynesonics, INC. | $63.57 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exact Sciences Corporation | $56.95 | 2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Myovant Sciences INC. | $54.29 | 2022 | |
| Aspira Women'S Health INC | $47.55 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $43.71 | 2022-2025 | |
| Dysis Medical, INC. | $36.05 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $33.10 | 2020 | |
| Seqirus USA INC | $28.75 | 2024 | Flucelvax |
| Allergan, INC. | $27.80 | 2019 | |
| Becton, Dickinson and Company | $27.13 | 2020 | |
| Sumitomo Pharma America, INC. | $25.79 | 2024 | Myfembree |
| Medtronic, INC. | $22.66 | 2023 | Truclear |
| Ferring Pharmaceuticals INC. | $17.64 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.13 | 2020 | |
| Boston Scientific Corporation | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Friedell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.